Want to see HK:0673 full AI Analyst Report?
0673 Stock Chart & Stats
HK$0.30
HK$0.03(9.09%)
At close: 4:00 PM EST
HK$0.30
HK$0.03(9.09%)
Day’s Range― - ―
52-Week RangeHK$0.25 - HK$0.86
Previous CloseN/A
Volume864.00K
Average Volume (3M)15.93K
Market Cap
HK$360.66M
Enterprise ValueHK$711.52M
Total Cash (Recent Filing)HK$21.95M
Total Debt (Recent Filing)HK$4.59M
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Nov 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding1,387,138,200
10 Day Avg. Volume2,680
30 Day Avg. Volume15,925
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)9.44
Price to Sales (P/S)12.24
P/FCF Ratio-5.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe sharp 2026 revenue rebound shows that the company retains some ability to generate renewed top-line activity after a weaker period. If this recovery persists, it could improve operating scale and provide a foundation for restoring profitability over the next several quarters.
Narrowing LossesA reduction in losses is an incremental improvement in earnings performance, even though profitability remains deeply negative. Continued narrowing would reduce the pace of capital erosion and could indicate that management is moving the business toward a more sustainable financial model.
Modest LeverageRelatively modest leverage during periods when equity was positive limits the direct burden of debt service and reduces near-term balance-sheet pressure. This provides more financial flexibility than a highly leveraged structure, although the benefit is weakened by inconsistent equity quality.
Bears Say
Persistent UnprofitabilityPersistent losses and extremely negative margins show that the current revenue base is not supporting a viable earnings model. Without a substantial improvement in operating economics, the company may continue eroding capital and have limited ability to fund growth internally.
Severe Cash BurnSustained negative operating cash flow means reported activity is not converting into cash needed to support operations. The very large 2026 outflow and consistently negative free cash flow indicate dependence on financing or balance-sheet support, limiting durable financial flexibility.
Weakening Balance SheetNegative equity represents a material weakness in the capital base, while shrinking assets point to a reduced balance-sheet footprint alongside the smaller historical revenue base. Together, these trends make recovery more dependent on sustained improvement rather than existing financial resources.
China Health Group News
0673 FAQ
What was China Health Group Ltd’s price range in the past 12 months?
China Health Group Ltd lowest stock price was HK$0.25 and its highest was HK$0.86 in the past 12 months.
What is China Health Group Ltd’s market cap?
China Health Group Ltd’s market cap is HK$360.66M.
When is China Health Group Ltd’s upcoming earnings report date?
China Health Group Ltd’s upcoming earnings report date is Nov 27, 2026 which is in 27 days.
How were China Health Group Ltd’s earnings last quarter?
China Health Group Ltd released its earnings results on Jun 30, 2026. The company reported -HK$0.027 earnings per share for the quarter.
Is China Health Group Ltd overvalued?
According to Wall Street analysts China Health Group Ltd’s price is currently Overvalued.
Does China Health Group Ltd pay dividends?
China Health Group Ltd does not currently pay dividends.
What is China Health Group Ltd’s EPS estimate?
China Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Ltd have?
China Health Group Ltd has 1,387,138,200 shares outstanding.
What happened to China Health Group Ltd’s price movement after its last earnings report?
China Health Group Ltd reported an EPS of -HK$0.027 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Health Group Ltd?
Currently, no hedge funds are holding shares in HK:0673
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Health Group Ltd
Serving as an investment holding company, China Health Group Limited engages in a diverse range of operations. Within the People's Republic of China, its core business involves the supply and maintenance of medical equipment and disposables, coupled with the administration and operation of healthcare facilities. The company also extends its activities into commercial factoring and real estate investment. Previously operating under the name China HealthCare Holdings Limited, the company officially adopted "China Health Group Limited" in September 2015. Its principal office is located in Central, Hong Kong.
Technical Analysis
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―